Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA grants Fast Track status to Sanofi's combined flu and COVID-19 vaccine for adults over 50.
The FDA has granted Fast Track designation to two combination vaccine candidates from Sanofi for preventing influenza and COVID-19 in individuals aged 50 and over.
These non-mRNA vaccines combine existing, approved vaccines for both diseases, which have shown high efficacy.
Ongoing clinical trials are assessing their safety and immune response.
6 Articles
La FDA otorga el estado de Fast Track a la vacuna combinada contra la gripe y COVID-19 de Sanofi para adultos mayores de 50 años.